Board Meeting9 Jun 2026, 07:03 pm
Goldline Pharma Approves FY26 Financial Results, Appoints Internal Auditor
AI Summary
Goldline Pharmaceutical Ltd announced the outcome of its Board Meeting held on June 9, 2026. The board approved the standalone audited financial results for the half-year and full year ended March 31, 2026. Additionally, M/s. Kunal Dutt & Associates were appointed as the Internal Auditor for the company starting from the financial year 2026-27. The financial results will be disseminated on the company's website. The meeting commenced at 4:30 PM and concluded at 5:06 PM.
Key Highlights
- Board approved audited financial results for FY26.
- Internal Auditor M/s. Kunal Dutt & Associates appointed.
- Appointment effective from FY2026-27.
- Results to be available on company website.
Price Impact
More from GLPL